REGCELL
RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
REGCELL
Industry:
Alternative Medicine Clinical Trials Outpatient Care
Founded:
2016-01-27
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.regcell.jp
Total Employee:
1+
Status:
Active
Total Funding:
640.67 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Nginx Microsoft Exchange Online
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ProfoundBio
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Future Venture Capital
Future Venture Capital investment in Venture Round - RegCell
Chuo Shinkin Venture Capital
Chuo Shinkin Venture Capital investment in Venture Round - RegCell
Fujifilm
Fujifilm investment in Venture Round - RegCell
Kagawa Securities
Kagawa Securities investment in Venture Round - RegCell
Nissay Capital
Nissay Capital investment in Venture Round - RegCell
SCREEN Holdings
SCREEN Holdings investment in Venture Round - RegCell
Japan Science and Technology Agency
Japan Science and Technology Agency investment in Venture Round - RegCell
Toho Holdings
Toho Holdings investment in Venture Round - RegCell
Official Site Inspections
http://www.regcell.jp
- Host name: www3783.sakura.ne.jp
- IP address: 163.43.80.93
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "RegCell"
RegCell - LinkedIn
RegCell | 564 followers on LinkedIn. Restoring Self-Tolerance to the Immune System to Transform the Treatment of Autoimmune Diseases | Based on the …See details»
RegCell
RegCell’s goal is to fundamentally change the way we treat autoimmune diseases by offering therapies that don’t simply address symptoms but provide function and balance to the immune …See details»
Japanese-Founded Regulatory T-cell Reprogramming Company …
Mar 18, 2025 RegCell is a global biotechnology company pioneering cell therapies for autoimmune diseases and transplantation. With newly established U.S. headquarters and …See details»
レグセル株式会社｜制御性T細胞による新たな免疫系 …
レグセル株式会社は、制御性T細胞を用いた新しい免疫系制御技術で自己免疫疾患やがんに対する革新的な医療を提供します。See details»
RegCell (JP) - [LSA] Life-Sciences-Asia.com - The East-West Life ...
RegCell is a global biotechnology company pioneering cell therapies for autoimmune diseases and transplantation. With newly established U.S. headquarters and deep roots in Japan’s …See details»
免疫系制御技術で自己免疫疾患やがんの新たなモダリ …
Mar 19, 2025 株式会社ファストトラックイニシアティブ（以下、「FTI」）が運営する投資事業有限責任組合は、制御性T細胞を用いた免疫系制御技術によ …See details»
レグセル株式会社｜J-Startup
レグセル株式会社 医...レグセル株式会社は、免疫学世界トップクラス研究者である坂口志文教授、河本宏教授の技術をもとに、新たな免疫関連医療の創出を …See details»
RegCell 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for RegCell. Use the PitchBook Platform to explore the full profile.See details»
Japanese-Founded Regulatory T-cell Reprogramming Company …
Mar 18, 2025 RegCell's scientific founder, Professor Shimon Sakaguchi, whose pioneering research led to the discovery of regulatory T cells (Tregs) and their essential function in …See details»
RegCell, Inc.. (3/18/25). "Press Release: Japanese-Founded …
Mar 23, 2025 RegCell is a global biotechnology company pioneering cell therapies for autoimmune diseases and transplantation. With newly established U.S. headquarters and …See details»
RegCell - Crunchbase Company Profile & Funding
Jan 27, 2016 RegCell is a novel therapeutics company that offers medical treatment to patients using regulatory T cells.See details»
Japanese-founded RegCell secures $45.8M in funding and …
Mar 18, 2025 RegCell is a global biotechnology company pioneering cell therapies for autoimmune diseases and transplantation. With newly established U.S. headquarters and …See details»
RegCell | F6S
RegCell - Biotech - Developing therapies for autoimmune diseases and transplantation.See details»
レグセル株式会社への新規投資について | 京都大学イノベーショ …
Sep 2, 2024 HP： https://regcell.jp/ 京都大学イノベーションキャピタル株式会社について 京都iCAPは、京都大学 100％出資子会社として、京都大学を中心とした国立大学から生まれた …See details»
Japan T-Reg Venture RegCell Raises New Funds, Relocates To US
Mar 26, 2025 A Japanese cell therapy venture RegCell relocated its HQ from Japan to US with $48.5m financing. (Shutterstock) Japanese regulatory T-cell (T-reg) venture RegCell has …See details»
レグセル株式会社｜投資先企業｜UTEC-東京大学エッジキャピタ …
レグセル株式会社｜投資先企業の紹介ページです。UTECは、東京大学が承認する「技術移転関連事業者」として、ベンチャー企業を通じた大学の「知」の社会還元に向けて、優れた知的 …See details»
RegCell Co., Ltd.｜Our Companies｜UTEC-The University of Tokyo …
Regcell Co., Ltd., founded in January 2016, aims to develop novel therapeutic technologies for autoimmune diseases, graft-versus-host disease, allergy and cancer through augmenting or …See details»
がん情報サイト「オンコロ」
がん情報サイト「オンコロ」は3Hメディソリューション株式会社が運営するWebサイトです。治験・臨床試験を中心とする、がん医療情報を患者さん・ご家族・またがん医療に関わる方々 …See details»
New Investment in Regcel Corporation | Kyoto University …
Sep 2, 2024 Representative Director: Michael McCullar HP: https://regcell.jp/ About Kyoto University Innovation Capital Co., Ltd. As a wholly-owned subsidiary of Kyoto University, …See details»
レグセル株式会社 | InfoBase
「Treg細胞療法」を開発するスタートアップ。Tregとは、自己免疫疾患やアレルギー、炎症性腸疾患、移植片対宿主病などの予防に効果が期待される抑制性細胞です。炎症を起こす原因細 …See details»